Merck’s Januvia, Medicare Pricing, And The Meaning of Patent Life

 
• By Cathy Kelly

Recent patent extension win for Januvia illustrates the dilemma that will be faced by manufacturers of older, single-source drugs that are chosen for price negotiation in the Medicare program.

Inflation Reduction Act Has Given New Meaning To Extending Patents • Source: Shutterstock

More from Pricing Debate

More from Market Access